Researchers from the University of Oregon (OR, USA) suggest that noninvasive EEG readings could present as easily detectable biomarkers to help diagnose and improve treatment for Parkinson’s and other motor disorders.
Enrollment in all ongoing Depatux-M studies has been halted for newly diagnosed glioblastoma due to lack of survival benefit.
Researchers have reported that individuals undergoing CAR T-cell therapy for blood cancers are at risk of neurological side effects; categorizing and understanding these side effects could be important in future diagnosis and treatment.
In this commentary from Future Neurology, the authors overview and compare cerebral organoids and other 3D aggregated cell cultures.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.